£61.99

CRC Press Cholesterol-Lowering Therapy: Evaluation of Clinical Trial Evidence

Price data last checked 16 day(s) ago - will refresh soon

View at Amazon

Price History & Forecast

Last 75 days • 75 data points (No recent data available)

Historical
Generating forecast...
£61.99 £60.52 £60.84 £61.16 £61.48 £61.80 £62.12 25 January 2026 12 February 2026 03 March 2026 21 March 2026 09 April 2026

Price Distribution

Price distribution over 75 days • 2 price levels

Days at Price
Current Price
4 days 71 days · current 0 18 36 53 71 £61 £62 Days at Price

Price Analysis

Most common price: £62 (71 days, 94.7%)

Price range: £61 - £62

Price levels: 2 different prices over 75 days

Description

Product Description Reveals important new results from clinical trials conducted in Scandinavia, Scotland, Australia, Canada, and the United States. This timely reference reviews the vast body of clinical trial evidence supporting the once controversial view that high levels of serum cholesterol are a major risk factor in coronary heart disease (CHD). The studies presented in Cholesterol-Lowering Therapy: Evaluation of Clinical Trial Evidence promote cholesterol reduction as a highly successful means of preventing heart disease in various populations. Investigates past, current, and upcoming controlled clinical trials of cholesterol-reduction therapies, comparing effects of statins and bile acid sequestrants to triglyceride-lowering drugs and antioxidants. Written by more than 25 distinguished international researchers, Cholesterol-Lowering Therapy: Evaluation of Clinical Trial Evidence highlights historical studies of dietary trials designed to reduce CHD covers tests of HMG CoA reductase inhibitors for patients with and without CHD illuminates CHD risk factors such as diabetes, hypertension, obesity, and smoking explores blood levels of homocysteine and lipoprotein(a) and other recently identified CHD risk factors reviews metabolism of lipoproteins expressed in high (HDL) and low (LDL) density lipoprotein cholesterol and more!Containing over 700 instructive tables, drawings, photographs, and bibliographic citations, Cholesterol-Lowering Therapy: Evaluation of Clinical Trial Evidence is a must-read resource for cardiologists, pharmacologists, and upper-level undergraduate, graduate, and medical school students in these disciplines. About the Author Scott M. Grundy

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
19 September 2019
Listed Since
25 June 2019

Barcode

No barcode data available

Similar Products You Might Like

Cholesterol-Lowering Therapy: Evaluation of Clinical Trial Evidence
99% match

Cholesterol-Lowering Therapy: Evaluation of Clinical Trial Evidence

CRC Press

£73.10 12 Dec 2025
Clinical Lipidology: A Companion to Braunwald's Heart Disease
93% match

Clinical Lipidology: A Companion to Braunwald's Heart Disease

Elsevier

£100.47 13 Jan 2026
Cholesterol, Lipoproteins, and Cardiovascular Health: Separating the Good (HDL), the Bad (LDL), and the Remnant
93% match

Cholesterol, Lipoproteins, and Cardiovascular Health: Separating the Good (HDL), the Bad (LDL), and the Remnant

£76.78 13 Jan 2026
Lipid Metabolism and Health
92% match

Lipid Metabolism and Health

CRC Press

£154.56 12 Jan 2026
Dyslipidemias: Pathophysiology, Evaluation and Management (Contemporary Endocrinology)
92% match

Dyslipidemias: Pathophysiology, Evaluation and Management (Contemporary Endocrinology)

Humana

£94.25 15 Apr 2026
Coronary Atherosclerosis: Current Management and Treatment
92% match

Coronary Atherosclerosis: Current Management and Treatment

CRC Press

£75.00 13 Jan 2026
Cholesterol in Atherosclerosis & Coronary Heart Disease
92% match

Cholesterol in Atherosclerosis & Coronary Heart Disease

£37.61 24 Jan 2026
Combination Therapy In Dyslipidemia
92% match

Combination Therapy In Dyslipidemia

Adis

£72.86 14 Apr 2026
Humana Dyslipidemias: Pathophysiology, Evaluation and Management
92% match

Humana Dyslipidemias: Pathophysiology, Evaluation and Management

Humana

£124.31 19 Apr 2026
The Cholesterol Wars: The Skeptics vs the Preponderance of Evidence
92% match

The Cholesterol Wars: The Skeptics vs the Preponderance of Evidence

Academic Press

£54.99 15 Apr 2026
Therapeutic Lipidology (Contemporary Cardiology)
92% match

Therapeutic Lipidology (Contemporary Cardiology)

Humana

£53.27 13 Jan 2026
Lipid Metabolism and Health
92% match

Lipid Metabolism and Health

CRC Press

£63.94 15 Apr 2026
Lipid-Lowering Therapy and Progression of Coronary Atherosclerosis: 180 (Developments in Cardiovascular Medicine, 180)
92% match

Lipid-Lowering Therapy and Progression of Coronary Atherosclerosis: 180 (Developments in Cardiovascular Medicine, 180)

Springer

£44.00 10 Mar 2026
Therapeutic Lipidology (Contemporary Cardiology)
92% match

Therapeutic Lipidology (Contemporary Cardiology)

Humana

£164.18 07 Jan 2026
Handbook of Stroke Prevention in Clinical Practice (Current Clinical Neurology)
92% match

Handbook of Stroke Prevention in Clinical Practice (Current Clinical Neurology)

Humana

£25.07 22 Feb 2026
CRC Press Clinical Guide to Antithrombotic Drugs in CAD
92% match

CRC Press Clinical Guide to Antithrombotic Drugs in CAD

CRC Press

£125.00 15 Apr 2026
Coronary Artery Disease: Therapeutics and Drug Discovery: 1177 (Advances in Experimental Medicine and Biology, 1177)
92% match

Coronary Artery Disease: Therapeutics and Drug Discovery: 1177 (Advances in Experimental Medicine and Biology, 1177)

Springer

£64.14 08 Mar 2026
Cardiovascular Outcomes Research: A Clinician’s Guide to Cardiovascular Epidemiology and Clinical Outcomes Trials (Contemporary Cardiology)
92% match

Cardiovascular Outcomes Research: A Clinician’s Guide to Cardiovascular Epidemiology and Clinical Outcomes Trials (Contemporary Cardiology)

£100.79 23 Jan 2026
Antithrombotic Drug Therapy in Cardiovascular Disease (Contemporary Cardiology)
92% match

Antithrombotic Drug Therapy in Cardiovascular Disease (Contemporary Cardiology)

Humana

£150.50 09 Mar 2026
The Portfolio Diet for Cardiovascular Disease Risk Reduction: An Evidence Based Approach to Lower Cholesterol through Plant Food Consumption
92% match

The Portfolio Diet for Cardiovascular Disease Risk Reduction: An Evidence Based Approach to Lower Cholesterol through Plant Food Consumption

Academic Press

£87.56 29 Jan 2026
High-Density Lipoproteins: Structure, Metabolism, Function and Therapeutics
92% match

High-Density Lipoproteins: Structure, Metabolism, Function and Therapeutics

Wiley

£111.49 08 Mar 2026
Statins: Medical Uses, Mechanisms of Action & Clinical Outcomes (Pharmacology-research, Safety Testing and Regulation)
92% match

Statins: Medical Uses, Mechanisms of Action & Clinical Outcomes (Pharmacology-research, Safety Testing and Regulation)

£126.21 12 Jan 2026
Resolving The Cholesterol Controversy: The Scientists Who Proved The Lipid Hypothesis Of Causation Of Atherosclerosis And Coronary Heart Disease
92% match

Resolving The Cholesterol Controversy: The Scientists Who Proved The Lipid Hypothesis Of Causation Of Atherosclerosis And Coronary Heart Disease

£63.87 07 Jan 2026
HDL & LDL Cholesterol: Physiology & Clinical Significance (Biochemistry Research Trends Series)
92% match

HDL & LDL Cholesterol: Physiology & Clinical Significance (Biochemistry Research Trends Series)

£88.51 07 Mar 2026